Stability studies gauge the preservation of a product's properties and characteristics within defined parameters, ensuring consistency from the moment of compounding throughout its storage and usage.
A stability-indicating method for API potency is an analytical technique designed to accurately determine the concentration or potency of the API in a pharmaceutical formulation while accounting for potential degradation products. This method is crucial for monitoring the stability of the API over time, ensuring that it retains its intended potency throughout its shelf life.
What tests are required and recommended?
Required
Potency assay
Appearance
Subvisible particulates
Antimicrobial Effectiveness Testing (Only final timepoint is required)
Container Closure Integrity
Recommended
pH, if applicable
Sterility (CCIT in lieu of sterility)
The two Phases of a Stability Study
Phase 1 consists of Stability Indicating Method and any validations and method suitability.
Phase 2 consists of the specified test carried out over the timepoints.
Example Phase 2 Timepoints
Test
T0
T30
T60
T90
Potency
✔
✔
✔
✔
pH
✔
✔
✔
✔
Appearance
✔
✔
✔
✔
Particulate <788>
✔
✔
✔
✔
CCIT
✔
✔
✔
✔
AET
✔
✔
Sterility
✔
Endotoxin
✔
1 Week
Quote process
Once questionnaire and initial meeting has been performed the quote will be available with in 1 week.
1 Week
Protocol Generation
Protocol will be generated with in 1 week of approved quote. Protocol will include testing, timepoints, sample requirements and more.
4-6 Weeks
Phase 1
Once P1 samples are received the testing usually takes 4-6 weeks for Method Suitability and Verifications
TP Dependent
Phase 2
Once P2 samples are received T0 test start immediately. Samples placed in appropriate storage conditions pending time points
3-4 Weeks
Final Report
The final stability study report will be available with in 4 week of final testing.
We use cookies to enhance your browsing experience. By continuing to use our site, you consent to our use of cookies. Learn more in our Privacy Policy.